ProfessorUCLA School of Dentistry
Disclosure information not submitted.
Natural Killer Cell-Based Immunotherapy Maintains Cytotoxicity after Temperature-Controlled Ablation in Poorly- and Well-differentiated Hepatocellular Carcinoma
Monday, March 25, 20244:21 PM – 4:30 PM MT
Supercharged Natural Killer Cell Immunotherapy vs. Standard Care Chemotherapy Drug Doxorubicin for Poorly- and Well-differentiated Hepatocellular Carcinoma In Vitro
Wednesday, March 27, 20243:00 PM – 3:09 PM MT